The Development and Regulation of Pharmaceuticals: Australian and International Perspectives

Prof Albert Frauman
Professor of Clinical Pharmacology and Therapeutics,
The University of Melbourne/Austin Health

Time: 18 June 2013, 18:00 AEDT (Refreshments from 17:30)

Venue: Engineering House, 21 Bedford St, North Melbourne, VIC 3051

Biography

Professor Albert Frauman graduated MBBS in 1979 and MD in 1990 from the University of Melbourne and is a Fellow of the Royal Australasian College of Physicians, the American College of Physicians and the American College of Clinical Pharmacology. He trained jointly in Clinical Pharmacology and Endocrinology at the Austin Hospital and did research postdocs in molecular biology at Harvard Medical School and the Walter and Eliza Hall Institute of Medical Research. After this, he established his own laboratory within the Clinical Pharmacology & Therapeutics Unit of the Department of Medicine at Austin Health/University of Melbourne. Albert was appointed the Foundation Director of the University’s Drug Evaluation Unit in 1993. This is an academic service which conducts evaluation of clinical trials data for the Therapeutic Goods Administration. More recently these activities expanded to assessment of pharmaceutical chemistry data for the New Zealand Government’s Medsafe. He has also been a member of the Pharmaceutical Benefits Advisory Committee (PBAC). In 2007, Albert was appointed Professor of Clinical Pharmacology & Therapeutics at the University of Melbourne. Albert has been involved in the development of curricula in Clinical Pharmacology and Therapeutics for the new MD course at the University of Melbourne and founded the University’s Postgraduate Diploma in Drug Evaluation and Pharmaceutical Sciences, which provided information on basic pharmacology, toxicology, pharmaceutical chemistry, clinical pharmacology, legal and ethical issues relating to drug development and regulation, and statistics and epidemiology. This was the first course of its kind in Australia and a number of other Universities have since followed suit. Finally, Albert has a number of hospital quality assurance activities, is Co-Director of the Victorian Poisons Information and Clinical Toxicology Service and is involved in inpatient and outpatient clinical medicine at Austin Health.